Denali Therapeutics Inc. (DNLI) — EPS (Diluted)
| Fiscal Year | EPS (Diluted) | Change YoY |
|---|---|---|
| 2025 | $-2.97 | -15.6% |
| 2024 | $-2.57 | -142.5% |
| 2023 | $-1.06 | +59.2% |
| 2022 | $-2.60 | -8.8% |
| 2021 | $-2.39 | -479.4% |
| 2020 | $0.63 | +130.4% |
| 2019 | $-2.07 | -430.8% |
| 2018 | $-0.39 | — |
| Fiscal Year | EPS (Diluted) | Change YoY |
|---|---|---|
| 2025 | $-2.97 | -15.6% |
| 2024 | $-2.57 | -142.5% |
| 2023 | $-1.06 | +59.2% |
| 2022 | $-2.60 | -8.8% |
| 2021 | $-2.39 | -479.4% |
| 2020 | $0.63 | +130.4% |
| 2019 | $-2.07 | -430.8% |
| 2018 | $-0.39 | — |